Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Examining the Impacts of HIV Antiretrovirals on Maternal Immune Homeostasis
EF 2021-22
Résumé
The World Health Organization recommends antiretroviral therapy (ART) for all people living with human immunodeficiency virus (HIV). This has transformed HIV into a chronic but manageable condition and greatly reduced the rate of HIV transmission from affected mothers to babies at the time of birth. However, ART in pregnancy has been associated with increased rates of preterm birth and small for gestational age babies. Healthy pregnancies rely on the placenta to provide growing fetuses with nutrients, oxygen, and protection from attack by the maternal immune system. A gap remains in the knowledge of the impact of different classes of antiretrovirals (ARVs) on placenta function and how this relates to poor fetal growth and birth outcomes. One potential mechanism is that ARV exposure dysregulates the maternal immune system, causing inflammation that is detrimental to the placenta and affecting pregnancy outcomes. To gain insight into these immunological processes, we will examine blood and placenta samples from pregnant women with HIV (pWHIV) being treated with ARVs from three clinical cohorts in Toronto, Uganda, and South Africa. We will focus on profiling the immune status (inflammatory vs. tolerogenic/non-inflammatory) of these women and identify immune blood markers that may be predictive of placental dysfunction and poor birth outcomes. Our findings may identify a mechanism of how different ARVs affect the placenta and which ARVs are safest to use in pregnancy. Our identified blood biomarkers will have potential applications to non-invasive liquid biopsies for the monitoring of pregnancies and predicting abnormal birth outcomes in pregnant women with HIV.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466709
Name
Cheung Michelle W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Examining the Impacts of HIV Antiretrovirals on Maternal Immune Homeostasis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Birth Outcomes; Antiretrovirals; Circulating Placenta Rna; Fetal Growth; Hiv; Immune Biomarkers; Inflammation; Maternal Immunology; Placenta; Pregnancy
Abstract
The World Health Organization recommends antiretroviral therapy (ART) for all people living with human immunodeficiency virus (HIV). This has transformed HIV into a chronic but manageable condition and greatly reduced the rate of HIV transmission from affected mothers to babies at the time of birth. However, ART in pregnancy has been associated with increased rates of preterm birth and small for gestational age babies. Healthy pregnancies rely on the placenta to provide growing fetuses with nutrients, oxygen, and protection from attack by the maternal immune system. A gap remains in the knowledge of the impact of different classes of antiretrovirals (ARVs) on placenta function and how this relates to poor fetal growth and birth outcomes. One potential mechanism is that ARV exposure dysregulates the maternal immune system, causing inflammation that is detrimental to the placenta and affecting pregnancy outcomes. To gain insight into these immunological processes, we will examine blood and placenta samples from pregnant women with HIV (pWHIV) being treated with ARVs from three clinical cohorts in Toronto, Uganda, and South Africa. We will focus on profiling the immune status (inflammatory vs. tolerogenic/non-inflammatory) of these women and identify immune blood markers that may be predictive of placental dysfunction and poor birth outcomes. Our findings may identify a mechanism of how different ARVs affect the placenta and which ARVs are safest to use in pregnancy. Our identified blood biomarkers will have potential applications to non-invasive liquid biopsies for the monitoring of pregnancies and predicting abnormal birth outcomes in pregnant women with HIV.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cheung, Michelle W
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~